<DOC>
	<DOC>NCT00415805</DOC>
	<brief_summary>This is an explorative small pilot study comparing two MRA contrast agents, one of which has been on the market for a few years and the other fairly new to the market. Since the study is explorative and designed to provide preliminary information for consideration for a future larger study, sample size is not based on statistical assumptions.</brief_summary>
	<brief_title>Renal MRA Crossover Study Comparing Multihance to Another Contrast Agent</brief_title>
	<detailed_description />
	<criteria>Known or suspected renovascular disease based on one of the following criteria: severe hypertension hypertension refractory to standard therapy abrupt onset of moderate to severe hypertension at age &lt; 35 years normalized blood pressure by an ACE inhibitor in a patient with moderate or severe hypertension unexplained by stable elevation of serum creatinine &gt; 2Mg/dL positive findings for stenosis from another imaging modality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>